Stay updated on GLPG1690 in IPF: ISABELA2 Clinical Trial
Sign up to get notified when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.

Latest updates to the GLPG1690 in IPF: ISABELA2 Clinical Trial page
- Check4 days agoChange DetectedThe sponsor name on the study record was updated from Galapagos NV to Lakefront Biotherapeutics NV, reflecting a change in the organization responsible for the trial. This affects the credited sponsor and the primary point of contact for study-related inquiries and regulatory documents.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision: v3.5.4 was added, replacing the previous v3.5.3 revision tag. This indicates a page version update rather than a substantive update to study details.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page’s footer shows an updated system/software release identifier, moving from “Revision: v3.5.2” to “Revision: v3.5.3”.SummaryDifference0.0%

- Check40 days agoChange DetectedIdiopathic Pulmonary Fibrosis is now listed on the page and a new Resources section for the Genetic and Rare Diseases Information Center has been added. The revision notes indicate an update to v3.5.2, replacing the prior v3.5.0.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved the Interstitial lung disease 2 entry and the Genetic and Rare Diseases Information Center resource from the page's Resources section.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed on the page.SummaryDifference0.0%

Stay in the know with updates to GLPG1690 in IPF: ISABELA2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.